![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print December 10, 2001
Centre de Biologie Structurale et de Bioinformatique, Université Libre de Bruxelles, Brussels 1050
Corresponding Author: cvigano{at}ulb.ac.be
The dynamical changes occurring during the catalytic cycle of Mdr3 P-glycoprotein (Pgp) and the role of each Nucleotide Binding Domains (NBD) in the transport process were investigated using Attenuated Total Reflection Fourier Transform Infrared spectroscopy (ATR-FTIR). For that purpose, Pgp wild type (WT) and two mutants in homologous residues of each NBDs were studied. On the one hand, we demonstrate here that during its catalytic cycle, Pgp does not undergo secondary structure changes but only modifications in its stability and accessibility towards the external environment. On the other hand, H/D exchange kinetics demonstrate that homologous mutations in the two NBDs affect in a different way the dynamical properties of Pgp and also the dynamical changes occurring during ATP hydrolysis. These observations lead to the conclusion that the NBDs have an asymmetric structure and different functions in the catalytic cycle of Pgp. Our data suggest that the release of drug from the membrane into the extracellular environment is due to a decreased stability and/or increased accessibility towards the external medium of the membrane-embedded drug binding site(s). NBD1 would play an important role in this first restructuration of the membrane-embedded domains. NBD2 would be directly implicated in a subsequent restructuration of the membrane-embedded binding sites by which they recover their initial stability and accessibility towards the membrane. It is proposed that this restructuration step would allow the binding and transport of another molecule of substrate.
J. Biol. Chem, 10.1074/jbc.M107928200
Submitted on August 17, 2001
Revised on December 7, 2001
Accepted on December 10, 2001
Structural and functional asymmetry of the nucleotide binding domains of P-glycoprotein investigated by attenuated total reflection fourier transform infrared spectroscopy
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Tombline, L. A. Bartholomew, G. A. Tyndall, K. Gimi, I. L. Urbatsch, and A. E. Senior Properties of P-glycoprotein with Mutations in the "Catalytic Carboxylate" Glutamate Residues J. Biol. Chem., November 5, 2004; 279(45): 46518 - 46526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Austermuhle, J. A. Hall, C. S. Klug, and A. L. Davidson Maltose-binding Protein Is Open in the Catalytic Transition State for ATP Hydrolysis during Maltose Transport J. Biol. Chem., July 2, 2004; 279(27): 28243 - 28250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yang, L. Cui, Y.-x. Hou, J. R. Riordan, and X.-b. Chang ATP Binding to the First Nucleotide Binding Domain of Multidrug Resistance-associated Protein Plays a Regulatory Role at Low Nucleotide Concentration, whereas ATP Hydrolysis at the Second Plays a Dominant Role in ATP-dependent Leukotriene C4 Transport J. Biol. Chem., August 15, 2003; 278(33): 30764 - 30771. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-x. Hou, J. R. Riordan, and X.-b. Chang ATP Binding, Not Hydrolysis, at the First Nucleotide-binding Domain of Multidrug Resistance-associated Protein MRP1 Enhances ADP{middle dot}Vi Trapping at the Second Domain J. Biol. Chem., January 31, 2003; 278(6): 3599 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manciu, X.-B. Chang, F. Buyse, Y.-X. Hou, A. Gustot, J. R. Riordan, and J. M. Ruysschaert Intermediate Structural States Involved in MRP1-mediated Drug Transport. ROLE OF GLUTATHIONE J. Biol. Chem., January 24, 2003; 278(5): 3347 - 3356. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |